Carbocysteine

羧甲司坦

Report date: 2023/02/27 20:00:18
NME

Base Information

Drug NameCarbocysteine
Drug Alias NameL-羧甲司坦CarbocisteineL-CarbocisteinMucodyneAHR-3053 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoughBronchiectasisMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsCough
Approved Indications in ChinaCough
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryEgyptSwitzerlandUnited Kingdom +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesQueen'S University BelfastKyorin Pharmaceutical Co LtdTanta University +[4] 
Inactive CompaniesDompé farmaceutici SPA
Active IndicationsCoughBronchiectasisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsBronchitis

Other Information

ATC CodeR05CB03
Related LinksWikipediaDrugBankKEGG